|
[1]
|
Liquid biopsies: the future of cancer early detection
Journal of Translational Medicine,
2023
DOI:10.1186/s12967-023-03960-8
|
|
|
|
|
[2]
|
Assessment of the
EarlyCDT‐Lung
test as an early biomarker of lung cancer in ever‐smokers: A retrospective nested case‐control study in two prospective cohorts
International Journal of Cancer,
2023
DOI:10.1002/ijc.34340
|
|
|
|
|
[3]
|
Screening approaches for lung cancer by blood-based biomarkers: Challenges and opportunities
Tumor Biology,
2023
DOI:10.3233/TUB-230004
|
|
|
|
|
[4]
|
Assessment of the EarlyCDT‐Lung test as an early biomarker of lung cancer in ever‐smokers: A retrospective nested case‐control study in two prospective cohorts
International Journal of Cancer,
2023
DOI:10.1002/ijc.34340
|
|
|
|
|
[5]
|
Development of an autoantibody panel for early detection of lung cancer in the Chinese population
Frontiers in Medicine,
2023
DOI:10.3389/fmed.2023.1209747
|
|
|
|
|
[6]
|
The Autoantibodies against Tumor-Associated Antigens as Potential Blood-Based Biomarkers in Thyroid Neoplasia: Rationales, Opportunities and Challenges
Biomedicines,
2022
DOI:10.3390/biomedicines10020468
|
|
|
|
|
[7]
|
Clinical validation of a spectroscopic liquid biopsy for earlier detection of brain cancer
Neuro-Oncology Advances,
2022
DOI:10.1093/noajnl/vdac024
|
|
|
|
|
[8]
|
Assessment of the
EarlyCDT‐Lung
test as an early biomarker of lung cancer in ever‐smokers: A retrospective nested case‐control study in two prospective cohorts
International Journal of Cancer,
2022
DOI:10.1002/ijc.34340
|
|
|
|
|
[9]
|
EarlyCDT Lung blood test for risk classification of solid pulmonary nodules: systematic review and economic evaluation
Health Technology Assessment,
2022
DOI:10.3310/IJFM4802
|
|
|
|
|
[10]
|
EarlyCDT Lung blood test for risk classification of solid pulmonary nodules: systematic review and economic evaluation
Health Technology Assessment,
2022
DOI:10.3310/IJFM4802
|
|
|
|
|
[11]
|
Prevalence, Association Relation, and Dynamic Evolution Analysis of Critical Values in Health Checkup in China: A Retrospective Study
Frontiers in Public Health,
2021
DOI:10.3389/fpubh.2021.630356
|
|
|
|
|
[12]
|
Cost-effectiveness of a new autoantibody test added to Computed Tomography (CT) compared to CT surveillance alone in the diagnosis of lung cancer amongst patients with indeterminate pulmonary nodules
PLOS ONE,
2020
DOI:10.1371/journal.pone.0237492
|
|
|
|
|
[13]
|
Biomarkers for Lung Cancer Screening and Detection
Cancer Epidemiology, Biomarkers & Prevention,
2020
DOI:10.1158/1055-9965.EPI-20-0865
|
|
|
|
|
[14]
|
Impact of a Rule-in Biomarker Test on Pulmonary Nodule Management: a survey of pulmonologists and thoracic surgeons
Clinical Lung Cancer,
2019
DOI:10.1016/j.cllc.2019.05.004
|
|
|
|
|
[15]
|
Cost-effectiveness of an autoantibody test (EarlyCDT-Lung) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules
PLOS ONE,
2018
DOI:10.1371/journal.pone.0197826
|
|
|
|